期刊文献+

结直肠癌肺转移预后因素及治疗策略 被引量:4

Therapeutic strategy and prognostic factors in colorectal cancer patients with pulmonary metastasis
原文传递
导出
摘要 结直肠癌患者发生肺转移一直被认为是结直肠癌的晚期事件,预后不良。而分析结直肠癌肺转移手术或非手术治疗患者的预后因素.根据预后因素分析结果选择正确的治疗方案,从而提高结直肠癌肺转移患者的生存期一直是困扰医生的难题。了解预后因素.对该类患者的治疗非常重要。 Patients with pulmonary metastasis from colorectal cancer have been considered to be associated with poor prognosis. It is a problem to improve survival for patients who suffer pulmonary metastasis from colorcctal cancer by analyzing the prognosis of patients who underwent pulmonary surgery or not and then choose the right treatment regimen. The identification of prognostic factors is particularly important in colorectal cancer patients with pulmonary metastasis.
出处 《中华胃肠外科杂志》 CAS 2012年第10期1017-1019,共3页 Chinese Journal of Gastrointestinal Surgery
关键词 结直肠肿瘤 肺转移 预后因素 Colorectal neoplasms Pulmonarymetastases Prognosis
  • 相关文献

参考文献1

共引文献11

同被引文献63

  • 1郑树.结直肠癌转移复发的转化医学研究[J].中华结直肠疾病电子杂志,2013,2(1):2-5. 被引量:2
  • 2周剑,王锡山.结直肠癌外周血循环肿瘤细胞的研究进展[J].中华结直肠疾病电子杂志,2013,2(1):25-28. 被引量:2
  • 3张京平,朱春富,王克俊,徐皓,王仕忠,朱平,高翔,吴文泽.手术操作对胃癌细胞外周血播散的影响及其危险因素[J].中华胃肠外科杂志,2007,10(3):234-237. 被引量:1
  • 4Kelly C, Cassidy J. Chemotherapy in metastatic colorectal cancer[J]. Surg Oncol,2007,16(1):65-70.
  • 5Rothbarth J, van de Velde CJ. Treatment of liver metas- tases of colorectal cancer[J]. Ann Oncol,2005,16(2):144-149.
  • 6Vogelsang H, Haas S, Hierholzer C, et al. Factors in- fluencing survival after resection of pulmonary metastases from colorectal cancer[J]. Br J Surg,2004,91(8): 1066-1071.
  • 7Meta-analysis Group in Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer[J]. J Clin On- co1,1998,16(1):301-308.
  • 8Sahz LB, Cox JV, Blanke C, et al. Irinotecan plus fluo- rouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group[J]. N Engl J Med,2000,343(13): 905-914.
  • 9Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial[J]. Lancet,2000, 355(9209): 1041-1047.
  • 10Toumigand C, Andre T, Achille E, et al. FOLFIRI fol- lowed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study[J]. J Clin Oncol,2004,22(2):229-237.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部